Medical Use
Scemblix is a kinase inhibitor prescribed for adult patients with:
- -Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), who have previously been treated with two or more tyrosine kinase inhibitors (TKIs).
- -Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP) with the T315I mutation.
Recommended Dosage:
- -For Ph+ CML in CP: Take 80 mg orally once daily or 40 mg twice daily.
- -For Ph+ CML in CP with the T315I mutation: Take 200 mg orally twice daily.
Administration Instructions:
- -Avoid eating for at least 2 hours before and 1 hour after taking Scemblix tablets.
- -Swallow the tablets whole; do not break, crush, or chew them.
Warning & Precautions
Patients receiving Asciminib have experienced neutropenia, thrombocytopenia, and anemia. It is essential to perform complete blood counts every 14 days for the first 3 months of treatment, and then monthly. Monitor patients for signs and symptoms of myelosuppression.
During therapy with Scemblix (20 mg or 40 mg), assess serum lipase and amylase levels monthly. Watch for signs and symptoms of pancreatic toxicity, especially in patients with a history of pancreatitis, who may require more frequent monitoring.
Hypertension has been observed in patients treated with Asciminib. Regularly monitor blood pressure and manage hypertension with standard antihypertensive therapy. For Grade 3 or higher hypertension, consider temporarily withholding, reducing the dose, or permanently discontinuing therapy based on the persistence of hypertension.
Hypersensitivity reactions have occurred in patients receiving Scemblix (40 mg or 20 mg). Monitor for signs and symptoms of hypersensitivity and initiate appropriate treatment. For Grade 3 or higher hypersensitivity, consider temporarily withholding, reducing the dose, or permanently discontinuing therapy depending on the persistence of hypersensitivity.
Cardiovascular toxicity, including arterial thrombotic and embolic conditions, ischemic cardiac and CNS conditions, and cardiac failure, has been reported in patients on Scemblix therapy. Assess patients with a history of cardiovascular risk factors for cardiovascular signs and symptoms.
Asciminib can cause fetal harm if administered to a pregnant woman. Verify the pregnancy status of females of reproductive age before starting treatment with Asciminib.
Documentation Availability
Documents required to import SCEMBLIX to India?
SCEMBLIX (asciminib) tablets can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii)Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing SCEMBLIX (Cancer Treatment Medicines) from around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
What is the Generic Name for the trade name drug Scemblix®?
Asciminib is Generic Name for the trade name drug Scemblix®.
What is the Manufacturer Name of Scemblix®?
Scemblix® is manufactured by Novartis Pharmaceuticals Corporation.
Is Scemblix® approved by the FDA?
Yes, Scemblix® is approved by the FDA. Date of approval: October 29, 2021.
What is Scemblix®?
Scemblix is an FDA approved medication used to treat adults with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).
What is the dosage and form of Scemblix® supplied?
Scemblix® is supplied as film-coated Tablets: 20 mg and 40 mg for oral administration.
What are the most common side effects due to Scemblix®?
Most common side effects due to Scemblix include: rash, upper respiratory tract infections, musculoskeletal pain, nausea, diarrhea, and fatigue.
How much does Scemblix cost in India?
The scemblix cost in India is very reasonable. In order to procure this Ph+ CML medication authentically, you can reach out to Rx4u team.
What are the storage conditions of Scemblix®?
Store scemblix tablets at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F). Dispense and store in the original container to protect from moisture.
Is it safe to buy Scemblix® online in India?
Yes, you can safely purchase scemblix online in India through https://rx4u.in/.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
